These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 10051701)

  • 1. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
    Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
    Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
    Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma.
    Barchuk W; Lambert J; Fuhr R; Jiang JZ; Bertelsen K; Fourie A; Liu X; Silkoff PE; Barnathan ES; Thurmond R
    Pulm Pharmacol Ther; 2014 Oct; 29(1):15-23. PubMed ID: 25018015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast.
    Minoguchi K; Kohno Y; Minoguchi H; Kihara N; Sano Y; Yasuhara H; Adachi M
    Chest; 2002 Mar; 121(3):732-8. PubMed ID: 11888953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual CysLT
    Gauvreau GM; Boulet LP; FitzGerald JM; Cockcroft DW; Davis BE; Leigh R; Tanaka M; Fourre JA; Tanaka M; Nabata T; O'Byrne PM
    Allergy; 2016 Dec; 71(12):1721-1727. PubMed ID: 27444660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation.
    Nadeem A; Obiefuna PC; Wilson CN; Mustafa SJ
    Eur J Pharmacol; 2006 Dec; 551(1-3):116-24. PubMed ID: 17027749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects.
    Gauvreau GM; Jordana M; Watson RM; Cockroft DW; O'Byrne PM
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1738-45. PubMed ID: 9412549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
    Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
    Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
    Hamilton AL; Watson RM; Wyile G; O'Byrne PM
    Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.
    Ramsay CF; Sullivan P; Gizycki M; Wang D; Swern AS; Barnes NC; Reiss TF; Jeffery PK
    Respir Med; 2009 Jul; 103(7):995-1003. PubMed ID: 19249198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
    Stelmach I; Jerzynska J; Kuna P
    J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.
    Leigh R; Vethanayagam D; Yoshida M; Watson RM; Rerecich T; Inman MD; O'Byrne PM
    Am J Respir Crit Care Med; 2002 Nov; 166(9):1212-7. PubMed ID: 12403690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
    Obase Y; Shimoda T; Tomari SY; Mitsuta K; Kawano T; Matsuse H; Kohno S
    Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
    Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma.
    Stelmach I; Jerzynska J; Kuna P
    Clin Exp Allergy; 2002 Feb; 32(2):264-9. PubMed ID: 11929492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
    Pavord I; Woodcock A; Parker D; Rice L;
    Respir Res; 2007 Sep; 8(1):67. PubMed ID: 17897478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory and lung function effects of montelukast in asthmatic volunteers exposed to sulfur dioxide.
    Gong H; Linn WS; Terrell SL; Anderson KR; Clark KW
    Chest; 2001 Feb; 119(2):402-8. PubMed ID: 11171715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of inhaled thiorphan on allergen-induced airway responses in asthmatic subjects.
    Diamant Z; Van der Veen H; Kuijpers EA; Bakker PF; Sterk PJ
    Clin Exp Allergy; 1996 May; 26(5):525-32. PubMed ID: 8735864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
    Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J
    Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.